Angiomyolipoma diagnostic study of choice: Difference between revisions

Jump to navigation Jump to search
← Older edit
VisualWikitext
Rekha (talk | contribs)
nocaptcha
1,129 edits
Gunnam (talk | contribs)
nocaptcha, Administrators
8,766 edits
 
(12 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Angiomyolipoma}}
{{Angiomyolipoma}}
{{CMG}}; {{AE}}
{{CMG}}; {{AE}} {{Faizan}}, {{Rekha}}  
== Overview ==
== Overview ==
There is no single [[diagnostic]] study of choice for the [[diagnosis]] of [[angiomyolipoma]], but [[angiomyolipoma]] can be diagnosed based on imaging studies and [[percutaneous]] [[biopsies]] depending upon the [[fat]] content of the [[lesion]], [[Bleeding|hemorrhage]], [[calcification]] or [[necrosis]].


== Diagnostic Study of Choice ==
== Diagnostic Study of Choice ==


=== Study of choice ===
=== Study of choice ===
There is no single diagnostic study of choice for the diagnosis of Angiomyolipoma, but Angiomyolipoma can be diagnosed based on imaging studies and percutaneous biopsies depending upon the fat content of the lesion,hemorrhage,calcification or necrosis.{{cite web |url=https://www.jbsr.be/articles/10.5334/jbsr.1536/#T2 |title=Renal Angiomyolipoma: The Good, the Bad, and the Ugly |format= |work= |accessdate=}}
* There is no single [[diagnostic]] study of choice for the [[diagnosis]] of [[angiomyolipoma]].
*[[Angiomyolipoma]] can be diagnosed based on imaging studies and [[percutaneous]] [[biopsies]] depending upon the following:<ref name="pmid19602467">{{cite journal| author=Sahni VA, Silverman SG| title=Biopsy of renal masses: when and why. | journal=Cancer Imaging | year= 2009 | volume= 9 | issue=  | pages= 44-55 | pmid=19602467 | doi=10.1102/1470-7330.2009.0005 | pmc=2739685 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19602467  }}</ref><ref name="pmid19414125">{{cite journal| author=Wang R, Wood DP| title=Evolving role of renal biopsy in small renal masses. | journal=Urol Oncol | year= 2009 | volume= 27 | issue= 3 | pages= 332-4 | pmid=19414125 | doi=10.1016/j.urolonc.2008.12.011 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19414125  }}</ref>
**[[Fat]] content of the [[Lesions|lesion]]
**[[Hemorrhage]]
**[[Calcification]] or [[necrosis]].<ref name="pmid16709793">{{cite journal| author=Silverman SG, Gan YU, Mortele KJ, Tuncali K, Cibas ES| title=Renal masses in the adult patient: the role of percutaneous biopsy. | journal=Radiology | year= 2006 | volume= 240 | issue= 1 | pages= 6-22 | pmid=16709793 | doi=10.1148/radiol.2401050061 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16709793  }}</ref><ref name="pmid25468637">{{cite journal| author=Schieda N, Kielar AZ, Al Dandan O, McInnes MD, Flood TA| title=Ten uncommon and unusual variants of renal angiomyolipoma (AML): radiologic-pathologic correlation. | journal=Clin Radiol | year= 2015 | volume= 70 | issue= 2 | pages= 206-20 | pmid=25468637 | doi=10.1016/j.crad.2014.10.001 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25468637  }}</ref>


OR
===== Name of Diagnostic Criteria =====
 
* There are no established criteria for the [[diagnosis]] of [[angiomyolipoma]].
[Disease name] is primarily diagnosed based on the clinical presentation.
 
OR
 
Investigations:
* Among the patients who present with clinical signs of [disease name], the [investigation name] is the most specific test for the diagnosis.
* Among the patients who present with clinical signs of [disease name], the [investigation name] is the most sensitive test for diagnosis.
* Among the patients who present with clinical signs of [disease name], the [investigation name] is the most efficient test for diagnosis.
 
==== The comparison of various diagnostic studies for [disease name] ====
{|
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | Test
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Sensitivity
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Specificity
|-
! style="background: #696969; color: #FFFFFF; text-align: center;" |Test 1
| style="background: #DCDCDC; padding: 5px; text-align: center;" |...%
| style="background: #DCDCDC; padding: 5px; text-align: center;" |...%
|-
! style="background: #696969; color: #FFFFFF; text-align: center;" |Test 2
| style="background: #DCDCDC; padding: 5px; text-align: center;" |...%
| style="background: #DCDCDC; padding: 5px; text-align: center;" |...%
|}
<small> [Name of test with higher sensitivity and specificity] is the preferred investigation based on the sensitivity and specificity</small>
 
===== Diagnostic results =====
The following finding(s) on performing [investigation name] is(are) confirmatory for [disease name]:
* [Finding 1]
* [Finding 2]
 
===== Sequence of Diagnostic Studies =====
The [name of investigation] must be performed when:
* The patient presented with symptoms/signs 1, 2, and 3 as the first step of diagnosis.
* A positive [test] is detected in the patient, to confirm the diagnosis.
 
OR
 
The various investigations must be performed in the following order:
* [Initial investigation]
* [2nd investigation]
 
=== Name of Diagnostic Criteria ===
 
'''It is recommended that you include the criteria in a table. Make sure you always cite the source of the content and whether the table has been adapted from another source.'''
 
[Disease name] is primarily diagnosed based on clinical presentation. There are no established criteria for the diagnosis of [disease name].
 
OR
 
There is no single diagnostic study of choice for [disease name], though [disease name] may be diagnosed based on [name of criteria] established by [...].
 
OR
 
The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met: [criterion 1], [criterion 2], [criterion 3], and [criterion 4].
 
OR
 
The diagnosis of [disease name] is based on the [criteria name] criteria, which includes [criterion 1], [criterion 2], and [criterion 3].
 
OR
 
[Disease name] may be diagnosed at any time if one or more of the following criteria are met:
* Criteria 1
* Criteria 2
* Criteria 3
 
OR
 
'''IF there are clear, established diagnostic criteria'''
 
The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met: [criterion 1], [criterion 2], [criterion 3], and [criterion 4].
 
OR
 
The diagnosis of [disease name] is based on the [criteria name] criteria, which include [criterion 1], [criterion 2], and [criterion 3].
 
OR
 
The diagnosis of [disease name] is based on the [definition name] definition, which includes [criterion 1], [criterion 2], and [criterion 3].
 
OR
 
'''IF there are no established diagnostic criteria'''
 
There are no established criteria for the diagnosis of [disease name].


==References==
==References==

Latest revision as of 15:56, 7 November 2019

Angiomyolipoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Angiomyolipoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Angiomyolipoma diagnostic study of choice On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Angiomyolipoma diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Angiomyolipoma diagnostic study of choice

CDC on Angiomyolipoma diagnostic study of choice

Angiomyolipoma diagnostic study of choice in the news

Blogs on Angiomyolipoma diagnostic study of choice

Directions to Hospitals Treating Angiomyolipoma

Risk calculators and risk factors for Angiomyolipoma diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2], Rekha, M.D.

Overview

There is no single diagnostic study of choice for the diagnosis of angiomyolipoma, but angiomyolipoma can be diagnosed based on imaging studies and percutaneous biopsies depending upon the fat content of the lesion, hemorrhage, calcification or necrosis.

Diagnostic Study of Choice

Study of choice

Name of Diagnostic Criteria

References

  1. ↑ Sahni VA, Silverman SG (2009). "Biopsy of renal masses: when and why". Cancer Imaging. 9: 44–55. doi:10.1102/1470-7330.2009.0005. PMC 2739685. PMID 19602467.
  2. ↑ Wang R, Wood DP (2009). "Evolving role of renal biopsy in small renal masses". Urol Oncol. 27 (3): 332–4. doi:10.1016/j.urolonc.2008.12.011. PMID 19414125.
  3. ↑ Silverman SG, Gan YU, Mortele KJ, Tuncali K, Cibas ES (2006). "Renal masses in the adult patient: the role of percutaneous biopsy". Radiology. 240 (1): 6–22. doi:10.1148/radiol.2401050061. PMID 16709793.
  4. ↑ Schieda N, Kielar AZ, Al Dandan O, McInnes MD, Flood TA (2015). "Ten uncommon and unusual variants of renal angiomyolipoma (AML): radiologic-pathologic correlation". Clin Radiol. 70 (2): 206–20. doi:10.1016/j.crad.2014.10.001. PMID 25468637.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Angiomyolipoma_diagnostic_study_of_choice&oldid=1588415"